LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Trametinib | 3.33 | uM | LJP5 | 1 | P20 | 72 | hr | 1334 | 2980 | 3930 | 0.7581 | 0.6744 |
BT-20 | Trametinib | 3.33 | uM | LJP5 | 2 | P20 | 72 | hr | 1334 | 3314 | 4051 | 0.8181 | 0.7643 |
BT-20 | Trametinib | 3.33 | uM | LJP5 | 3 | P20 | 72 | hr | 1334 | 3025 | 4117 | 0.7346 | 0.6544 |
BT-20 | Trametinib | 10 | uM | LJP5 | 1 | P19 | 72 | hr | 1334 | 3344 | 3930 | 0.8507 | 0.8029 |
BT-20 | Trametinib | 10 | uM | LJP5 | 2 | P19 | 72 | hr | 1334 | 3662 | 4051 | 0.9040 | 0.8778 |
BT-20 | Trametinib | 10 | uM | LJP5 | 3 | P19 | 72 | hr | 1334 | 3570 | 4117 | 0.8670 | 0.8319 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 1 | N06 | 72 | hr | 1334 | 1212 | 3955 | 0.3064 | -0.0597 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 2 | N06 | 72 | hr | 1334 | 1167 | 3899 | 0.2993 | -0.0831 |
BT-20 | Omipalisib | 0.04 | uM | LJP6 | 3 | N06 | 72 | hr | 1334 | 1159 | 3921 | 0.2956 | -0.0868 |
BT-20 | Omipalisib | 0.12 | uM | LJP6 | 1 | N05 | 72 | hr | 1334 | 1009 | 3955 | 0.2551 | -0.1634 |
BT-20 | Omipalisib | 0.12 | uM | LJP6 | 2 | N05 | 72 | hr | 1334 | 1084 | 3899 | 0.2780 | -0.1259 |
BT-20 | Omipalisib | 0.12 | uM | LJP6 | 3 | N05 | 72 | hr | 1334 | 1043 | 3921 | 0.2660 | -0.1467 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 1 | N04 | 72 | hr | 1334 | 843 | 3955 | 0.2131 | -0.2541 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 2 | N04 | 72 | hr | 1334 | 901 | 3899 | 0.2311 | -0.2244 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 3 | N04 | 72 | hr | 1334 | 824 | 3921 | 0.2101 | -0.2667 |
BT-20 | Omipalisib | 1.11 | uM | LJP6 | 1 | N03 | 72 | hr | 1334 | 879 | 3955 | 0.2222 | -0.2339 |
BT-20 | Omipalisib | 1.11 | uM | LJP6 | 2 | N03 | 72 | hr | 1334 | 614 | 3899 | 0.1575 | -0.3947 |
BT-20 | Omipalisib | 1.11 | uM | LJP6 | 3 | N03 | 72 | hr | 1334 | 710 | 3921 | 0.1811 | -0.3337 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1334 | 665 | 3955 | 0.1681 | -0.3588 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1334 | 539 | 3899 | 0.1382 | -0.4436 |
BT-20 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1334 | 494 | 3921 | 0.1260 | -0.4723 |
BT-20 | Omipalisib | 10 | uM | LJP6 | 1 | N01 | 72 | hr | 1334 | 520 | 3955 | 0.1315 | -0.4519 |
BT-20 | Omipalisib | 10 | uM | LJP6 | 2 | N01 | 72 | hr | 1334 | 430 | 3899 | 0.1103 | -0.5192 |
BT-20 | Omipalisib | 10 | uM | LJP6 | 3 | N01 | 72 | hr | 1334 | 488 | 3921 | 0.1245 | -0.4764 |
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 1 | H06 | 72 | hr | 1334 | 3947 | 3930 | 1.0041 | 1.0053 |